Cargando…

Integrative metabolome and lipidome analyses of plasma in neovascular macular degeneration

Age-related macular degeneration (AMD) causes irreversible vision-loss among the elderly in industrial countries. Neovascular AMD (nAMD), which refers to late-stage AMD, is characterized by severe vision-threatening choroidal neovascularization (CNV). Herein, we constructed a global metabolic networ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Tantai, Li, Jiani, Wang, Yanbin, Guo, Xiaojian, Sun, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539639/ https://www.ncbi.nlm.nih.gov/pubmed/37780745 http://dx.doi.org/10.1016/j.heliyon.2023.e20329

Ejemplares similares

Iron Accumulation and Lipid Peroxidation in the Aging Retina: Implication of Ferroptosis in Age-Related Macular Degeneration
por: Zhao, Tantai, et al.
Publicado: (2021)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
por: Mitchell, Sabrina L., et al.
Publicado: (2021)

Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China
por: Zhao, Tantai, et al.
Publicado: (2023)

Metabolome-Wide Association Study of Neovascular Age-Related Macular Degeneration
por: Osborn, Melissa P., et al.
Publicado: (2013)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Association of plasma trace element levels with neovascular age-related macular degeneration
por: Heesterbeek, Thomas J., et al.
Publicado: (2020)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

Profile of conbercept in the treatment of neovascular age-related macular degeneration
por: Lu, Xinmin, et al.
Publicado: (2015)

EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration
por: Cheng, Lu, et al.
Publicado: (2021)

Radiation therapy for neovascular age-related macular degeneration
por: Petrarca, Robert, et al.
Publicado: (2011)

Experimental Models in Neovascular Age Related Macular Degeneration
por: Rastoin, Olivia, et al.
Publicado: (2020)

Pipeline therapies for neovascular age related macular degeneration
por: Arepalli, Sruthi, et al.
Publicado: (2021)

Association of neovascular age-related macular degeneration with migraine
por: Kuang, Tung-Mei, et al.
Publicado: (2022)

Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
por: Wang, Yusong, et al.
Publicado: (2022)

Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Shen, Yinchen, et al.
Publicado: (2022)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Plasma level of lipocalin 2 is increased in neovascular age-related macular degeneration patients, particularly those with macular fibrosis
por: Chen, Mei, et al.
Publicado: (2020)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
por: Arrigo, Alessandro, et al.
Publicado: (2021)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2023)

LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma
por: Liu, Xiang, et al.
Publicado: (2020)

Integrated Analysis of Metabolomics and Lipidomics in Plasma of T2DM Patients with Diabetic Retinopathy
por: Ding, Chun, et al.
Publicado: (2022)

Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients
por: Arévalo, Cindy, et al.
Publicado: (2023)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

Segmentation of macular neovascularization and leakage in fluorescein angiography images in neovascular age-related macular degeneration using deep learning
por: Holomcik, David, et al.
Publicado: (2022)

Revealing Further Insights into Astringent Seeds of Chinese Fir by Integrated Metabolomic and Lipidomic Analyses
por: Zheng, Ping, et al.
Publicado: (2023)

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Treatment of neovascular age-related macular degeneration: Current therapies
por: Augustin, Albert J, et al.
Publicado: (2009)

Treatment of neovascular age-related macular degeneration in patients with diabetes
por: Cummings, Michael, et al.
Publicado: (2008)

Phacoemulsification Surgery in Eyes with Neovascular Age-Related Macular Degeneration
por: Grixti, Andre, et al.
Publicado: (2014)

Treatment of age-related neovascular macular degeneration: the patient’s perspective
por: Müller, S., et al.
Publicado: (2017)

Spironolactone as an Adjunctive Treatment in Neovascular Age-Related Macular Degeneration
por: Kapoor, Kapil G., et al.
Publicado: (2017)

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
por: Kapoor, Kapil G., et al.
Publicado: (2016)

Progression of subclinical choroidal neovascularization in age-related macular degeneration
por: Heiferman, Michael J., et al.
Publicado: (2019)

Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
por: Samanta, Anindya, et al.
Publicado: (2020)

Levodopa Positively Affects Neovascular Age-Related Macular Degeneration
por: Figueroa, Anna G., et al.
Publicado: (2020)

Personalized Approach in Treatment of Neovascular Age-Related Macular Degeneration
por: Kirkova, Radina, et al.
Publicado: (2022)

Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration
por: Chandra, Shruti, et al.
Publicado: (2023)

Brolucizumab for Neovascular Age-Related Macular Degeneration (BEL Study)
por: Van Cleemput, Liesbeth, et al.
Publicado: (2023)

Metabolomics and Age-Related Macular Degeneration
por: Brown, Connor N., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f78v2kcq1ohtdbehmuok1ptcjo